# Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule

> **NCT00480116** · PHASE3 · COMPLETED · sponsor: **Henogen** · enrollment: 450 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Adjuvanted Hepatitis B vaccine Lot 1
- **BIOLOGICAL:** Adjuvanted Hepatitis B vaccine Lot 2
- **BIOLOGICAL:** Adjuvanted Hep B vaccine Lot 3

## Key facts

- **NCT ID:** NCT00480116
- **Lead sponsor:** Henogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2008-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480116, "Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00480116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*